Mitsubishi UFJ Trust & Banking Corp Cuts Stock Position in Maximus, Inc. $MMS

Key Points

• 61.2% stake reduction by Mitsubishi UFJ Trust & Banking Corp in Q4, selling 15,572 shares and leaving 9,865 shares valued at $852,000.
• CEO Bruce Caswell bought 3,175 shares at $78.45 on Feb. 10, raising his holdings to 328,013 shares (a 0.98% increase), while a director sold a small position.
• Several brokerages downgraded Maximus to a "Hold" and the consensus rating is Hold; the company slightly beat EPS estimates ($1.85 vs. $1.84) but revenue fell 4.1% year-over-year and FY2026 guidance is $8.05–$8.35 EPS.

Mitsubishi UFJ Trust & Banking Corp lessened its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 61.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,865 shares of the health services provider's stock after selling 15,572 shares during the period. Mitsubishi UFJ Trust & Banking Corp's holdings in Maximus were worth $852,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its stake in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Richardson Financial Services Inc. grew its stake in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 192 shares during the last quarter. Advisory Services Network LLC purchased a new position in Maximus in the third quarter valued at about $32,000. Canada Pension Plan Investment Board purchased a new stake in shares of Maximus during the second quarter worth about $35,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in shares of Maximus during the third quarter worth about $38,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Buying and Selling

In other news, CEO Bruce Caswell bought 3,175 shares of the firm's stock in a transaction that occurred on Tuesday, February 10th. The stock was purchased at an average price of $78.45 per share, with a total value of $249,078.75. Following the completion of the acquisition, the chief executive officer directly owned 328,013 shares of the company's stock, valued at $25,732,619.85. This trade represents a 0.98% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jan Madsen sold 742 shares of Maximus stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director directly owned 20,795 shares of the company's stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MMS. Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Monday, February 23rd. Zacks Research lowered Maximus from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 27th. Finally, Weiss Ratings lowered Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of "Hold".

Maximus Price Performance

Shares of MMS stock opened at $65.29 on Wednesday. Maximus, Inc. has a fifty-two week low of $60.75 and a fifty-two week high of $100.00. The firm has a market capitalization of $3.56 billion, a price-to-earnings ratio of 9.94 and a beta of 0.60. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. The stock's 50-day simple moving average is $69.11 and its 200-day simple moving average is $80.28.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the previous year, the company posted $1.61 earnings per share. The company's revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts forecast that Maximus, Inc. will post 8.46 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. Maximus's payout ratio is 20.09%.

About Maximus

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.